Virbac has completed the acquisition of the remaining minority shares of Globion, an Indian poultry vaccines specialist, making it the sole owner of the company. This acquisition follows the major acquisition of a 74% stake concluded on November 1, 2023. Founded in 2005 as a joint venture between India’s Suguna Group and Germany’s Lohmann Animal Health, Globion has established expertise in the development, manufacture, and commercialization of vaccines for avian pathogens. Based in Hyderabad, Globion recorded approximately $12 million in revenue in 2023 and employs about 120 full-time staff. Virbac, a global leader in providing animal health solutions, aims to enhance its portfolio of products and services through this acquisition.

Animal Health, Poultry Farming,India, France